Oncology

Several factors contribute to patients’ perception of a good death from cancer

Aug 10, 2023

Bookmark1. In this systematic review, seven core elements of a good death among cancer patients...

Talazoparib plus enzalutamide improves progression-free survival in metastatic prostate cancer

Aug 9, 2023

Bookmark1. Progression-free survival was significantly higher in the talazoparib plus enzalutamide...

Reducing the screening age for colorectal cancer in Canada to 40 or 45 may result in fewer cases, less mortality, and reduced healthcare spending costs

Aug 8, 2023

Bookmark1. Initiating colorectal cancer screening at age 45 results in 12,188 fewer cases and...

Integrated Clinical-Molecular Classification of Colorectal Liver Metastases

Aug 8, 2023

Bookmark1. The immune subtype demonstrated an improved progression-free survival (HR 0.37) and...

Spirituality may benefit patients with a diagnosis of prostate cancer

Aug 5, 2023

Bookmark1. In this systematic review, most articles reported a positive association between...

Atezolizumab added to cabozantinib does not improve clinical outcomes in patients with metastatic renal cell carcinoma

Aug 2, 2023

Bookmark1. Progression-free and overall survival was comparable in both the intervention and...

Higher cardiorespiratory fitness may be protective against breast cancer in postmenopausal women

Jul 29, 2023

Bookmark1. In this prospective cohort study, higher cardiorespiratory fitness (CRF) was associated...

Fruquintinib significantly improves survival in patients with refractory metastatic colorectal cancer

Jul 20, 2023

Bookmark1. Overall survival was significantly greater in the fruquintinib group versus placebo. 2....

Checkpoint Inhibitors With Radiotherapy in Patients With Advanced Solid Tumors

Jul 18, 2023

Bookmark1. Stereotactic body radiotherapy in addition to immune checkpoint inhibitors has similar...

Long telomere syndrome is associated with an increased risk of developing neoplasms

Jul 18, 2023

Bookmark1. In this case series, protection of telomeres 1 (POT1) mutations associated with long...

Adjuvant treatment with programmed cell death receptor-1 inhibitor pembrolizumab is an effective adjuvant treatment for stage III/IV melanoma

Jul 16, 2023

Bookmark1. Five-year disease-free survival was greater in patients who had ≤10% viable tumour or...

Gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma

Jul 16, 2023

Bookmark1. Combination therapy with gemcitabine and docetaxel for patients with metastatic or...

Younger age may be a poor prognostic factor in patients with metastatic colon cancer

Jul 16, 2023

Bookmark1. In this retrospective cohort study, patients younger than 50 with metastatic colorectal cancer (mCRC) had significantly shorter progression-free survival and overall survival rates compared with those aged 50 to 65...

Dose-escalated simultaneous integrated boost radiotherapy may increase ipsilateral breast tumor relapse rates

Jul 16, 2023

Bookmark1. 5-year ipsilateral breast tumor relapse rates for test group 1 were non-inferior to the control group. However, noninferiority was not shown with test group 2 versus control. 2. Test group 2 was found to have a higher...